Effect of potassium depletion on gentamicin nephrotoxicity

Karl R. Brinker, Ruth Ellen Bulger, Dennis C. Dobyan, Timothy R. Stacey, Paul M. Southern, William L. Henrich, Robert E. Cronin

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Hypokalemia and potassium wasting occur after gentamicin administration. This study assesses the importance of prior potassium depletion on the development of gentamicin nephrotoxicity in the following three groups of dogs: group I, low-potassium diet for 1 week followed by a sham injection for 10 days; group II, low-potassium diet for 1 week followed by gentamicin (15 mg/kg twice daily) for 10 days; group III, potassium-supplemented diet for 1 week followed by the identical dose of gentamicin for 10 days. Groups I and II also received intramuscular DOCA for the first 5 days. Plasma creatinine (mean ± S.E.M.) changes occurring over the 10 day injection period were as follows: group I, 1.1± 0.1 mg/dl to 1.5 ± 0.2, NS; group II, 1.0 ± 0.1 to 15.8 ± 1.8, p < 0.01; and group III, 1.1 ± 0.1 to 3.5 ± 1.1, p < 0.05. Plasma creatinines differed significantly between groups II and III on days 6, 8, and 10. Urinary potassium loss during the 10-day injection period was greater in group II than in group I (2.9 ± 0.5 mEq/kg vs. 0.6 ± 0.2, p < 0.001). Renal cortical gentamicin levels at the end of the 10-day injection period were higher in group II than in group III (673 ± 54 μg/gm vs. 483 ± 59, p < 0.001). Proximal tubular necrosis occurred only in animals receiving gentamicin (groups II and III), was most prominent in the superficial and outer cortex, and correlated (r = 0.91, p < 0.001) with renal functional impairment. These data indicate that potassium depletion potentiates gentamicin nephrotoxicity and that gentamicin nephrotoxicity itself induces potassium wasting.

Original languageEnglish (US)
Pages (from-to)292-301
Number of pages10
JournalThe Journal of Laboratory and Clinical Medicine
Volume98
Issue number2
StatePublished - 1981

Fingerprint

Gentamicins
Potassium
Nutrition
Injections
Diet
Creatinine
Desoxycorticosterone Acetate
Kidney
Plasmas
Hypokalemia
Animals
Necrosis
Dogs
Scanning electron microscopy

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Brinker, K. R., Bulger, R. E., Dobyan, D. C., Stacey, T. R., Southern, P. M., Henrich, W. L., & Cronin, R. E. (1981). Effect of potassium depletion on gentamicin nephrotoxicity. The Journal of Laboratory and Clinical Medicine, 98(2), 292-301.

Effect of potassium depletion on gentamicin nephrotoxicity. / Brinker, Karl R.; Bulger, Ruth Ellen; Dobyan, Dennis C.; Stacey, Timothy R.; Southern, Paul M.; Henrich, William L.; Cronin, Robert E.

In: The Journal of Laboratory and Clinical Medicine, Vol. 98, No. 2, 1981, p. 292-301.

Research output: Contribution to journalArticle

Brinker, KR, Bulger, RE, Dobyan, DC, Stacey, TR, Southern, PM, Henrich, WL & Cronin, RE 1981, 'Effect of potassium depletion on gentamicin nephrotoxicity', The Journal of Laboratory and Clinical Medicine, vol. 98, no. 2, pp. 292-301.
Brinker KR, Bulger RE, Dobyan DC, Stacey TR, Southern PM, Henrich WL et al. Effect of potassium depletion on gentamicin nephrotoxicity. The Journal of Laboratory and Clinical Medicine. 1981;98(2):292-301.
Brinker, Karl R. ; Bulger, Ruth Ellen ; Dobyan, Dennis C. ; Stacey, Timothy R. ; Southern, Paul M. ; Henrich, William L. ; Cronin, Robert E. / Effect of potassium depletion on gentamicin nephrotoxicity. In: The Journal of Laboratory and Clinical Medicine. 1981 ; Vol. 98, No. 2. pp. 292-301.
@article{7c29b269d13c444b87294989598297c0,
title = "Effect of potassium depletion on gentamicin nephrotoxicity",
abstract = "Hypokalemia and potassium wasting occur after gentamicin administration. This study assesses the importance of prior potassium depletion on the development of gentamicin nephrotoxicity in the following three groups of dogs: group I, low-potassium diet for 1 week followed by a sham injection for 10 days; group II, low-potassium diet for 1 week followed by gentamicin (15 mg/kg twice daily) for 10 days; group III, potassium-supplemented diet for 1 week followed by the identical dose of gentamicin for 10 days. Groups I and II also received intramuscular DOCA for the first 5 days. Plasma creatinine (mean ± S.E.M.) changes occurring over the 10 day injection period were as follows: group I, 1.1± 0.1 mg/dl to 1.5 ± 0.2, NS; group II, 1.0 ± 0.1 to 15.8 ± 1.8, p < 0.01; and group III, 1.1 ± 0.1 to 3.5 ± 1.1, p < 0.05. Plasma creatinines differed significantly between groups II and III on days 6, 8, and 10. Urinary potassium loss during the 10-day injection period was greater in group II than in group I (2.9 ± 0.5 mEq/kg vs. 0.6 ± 0.2, p < 0.001). Renal cortical gentamicin levels at the end of the 10-day injection period were higher in group II than in group III (673 ± 54 μg/gm vs. 483 ± 59, p < 0.001). Proximal tubular necrosis occurred only in animals receiving gentamicin (groups II and III), was most prominent in the superficial and outer cortex, and correlated (r = 0.91, p < 0.001) with renal functional impairment. These data indicate that potassium depletion potentiates gentamicin nephrotoxicity and that gentamicin nephrotoxicity itself induces potassium wasting.",
author = "Brinker, {Karl R.} and Bulger, {Ruth Ellen} and Dobyan, {Dennis C.} and Stacey, {Timothy R.} and Southern, {Paul M.} and Henrich, {William L.} and Cronin, {Robert E.}",
year = "1981",
language = "English (US)",
volume = "98",
pages = "292--301",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Effect of potassium depletion on gentamicin nephrotoxicity

AU - Brinker, Karl R.

AU - Bulger, Ruth Ellen

AU - Dobyan, Dennis C.

AU - Stacey, Timothy R.

AU - Southern, Paul M.

AU - Henrich, William L.

AU - Cronin, Robert E.

PY - 1981

Y1 - 1981

N2 - Hypokalemia and potassium wasting occur after gentamicin administration. This study assesses the importance of prior potassium depletion on the development of gentamicin nephrotoxicity in the following three groups of dogs: group I, low-potassium diet for 1 week followed by a sham injection for 10 days; group II, low-potassium diet for 1 week followed by gentamicin (15 mg/kg twice daily) for 10 days; group III, potassium-supplemented diet for 1 week followed by the identical dose of gentamicin for 10 days. Groups I and II also received intramuscular DOCA for the first 5 days. Plasma creatinine (mean ± S.E.M.) changes occurring over the 10 day injection period were as follows: group I, 1.1± 0.1 mg/dl to 1.5 ± 0.2, NS; group II, 1.0 ± 0.1 to 15.8 ± 1.8, p < 0.01; and group III, 1.1 ± 0.1 to 3.5 ± 1.1, p < 0.05. Plasma creatinines differed significantly between groups II and III on days 6, 8, and 10. Urinary potassium loss during the 10-day injection period was greater in group II than in group I (2.9 ± 0.5 mEq/kg vs. 0.6 ± 0.2, p < 0.001). Renal cortical gentamicin levels at the end of the 10-day injection period were higher in group II than in group III (673 ± 54 μg/gm vs. 483 ± 59, p < 0.001). Proximal tubular necrosis occurred only in animals receiving gentamicin (groups II and III), was most prominent in the superficial and outer cortex, and correlated (r = 0.91, p < 0.001) with renal functional impairment. These data indicate that potassium depletion potentiates gentamicin nephrotoxicity and that gentamicin nephrotoxicity itself induces potassium wasting.

AB - Hypokalemia and potassium wasting occur after gentamicin administration. This study assesses the importance of prior potassium depletion on the development of gentamicin nephrotoxicity in the following three groups of dogs: group I, low-potassium diet for 1 week followed by a sham injection for 10 days; group II, low-potassium diet for 1 week followed by gentamicin (15 mg/kg twice daily) for 10 days; group III, potassium-supplemented diet for 1 week followed by the identical dose of gentamicin for 10 days. Groups I and II also received intramuscular DOCA for the first 5 days. Plasma creatinine (mean ± S.E.M.) changes occurring over the 10 day injection period were as follows: group I, 1.1± 0.1 mg/dl to 1.5 ± 0.2, NS; group II, 1.0 ± 0.1 to 15.8 ± 1.8, p < 0.01; and group III, 1.1 ± 0.1 to 3.5 ± 1.1, p < 0.05. Plasma creatinines differed significantly between groups II and III on days 6, 8, and 10. Urinary potassium loss during the 10-day injection period was greater in group II than in group I (2.9 ± 0.5 mEq/kg vs. 0.6 ± 0.2, p < 0.001). Renal cortical gentamicin levels at the end of the 10-day injection period were higher in group II than in group III (673 ± 54 μg/gm vs. 483 ± 59, p < 0.001). Proximal tubular necrosis occurred only in animals receiving gentamicin (groups II and III), was most prominent in the superficial and outer cortex, and correlated (r = 0.91, p < 0.001) with renal functional impairment. These data indicate that potassium depletion potentiates gentamicin nephrotoxicity and that gentamicin nephrotoxicity itself induces potassium wasting.

UR - http://www.scopus.com/inward/record.url?scp=0019456784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019456784&partnerID=8YFLogxK

M3 - Article

C2 - 7252335

AN - SCOPUS:0019456784

VL - 98

SP - 292

EP - 301

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 2

ER -